project id: TCGA-SKCM; case submitter id: TCGA-FS-A1Z0; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 8.5; age at index: 32; days to birth: -11815; days to death: 6164; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1958; year of death: 2006; age at diagnosis: 11815; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1a; ajcc staging system edition: 3rd; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C44.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 1990; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 7435; initial weight: 360.0; oct embedded: false; preservation method: Unknown; sample id: 5b0f64d4-6052-4465-8ad9-058556ec9aa3; sample submitter id: TCGA-FS-A1Z0-06A; portion id: c780bdcb-475b-49b9-8ff4-389363637ceb; portion submitter id: TCGA-FS-A1Z0-06A-11; slide id: ad7f2735-d7c3-4f26-96e8-c665f9b8a321; slide submitter id: TCGA-FS-A1Z0-06A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0; section location: TOP;